Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients

• Published in: Indian journal of dermatology, venereology, and leprology venereology, and leprology, 2015-01, Vol.81 (1), p.16-22
• Main Authors: Tamhankar, Parag M, Iyer, Shruti V, Ravindran, Shyla, Gupta, Neerja, Kabra, Madhulika, Nayak, Chitra, Kura, Mahendra, Sanghavi, Swapnil, Joshi, Rajesh, Chennuri, Vasundhara Sridhar, Khopkar, Uday
• Format: Article
• Language: English
• Subjects: Adult; Automation; Child; Child, Preschool; Deoxyribonucleic acid; DNA; DNA Helicases - genetics; DNA Mutational Analysis; DNA repair; DNA-Binding Proteins - genetics; Families & family life; Female; Gene mutations; Genes; Genetic aspects; Genetic counseling; Genetic testing; Health aspects; Homozygote; Humans; India; Intellectual Disability - genetics; Male; Mutation; Novels; Patients; Risk factors; Tumors; Xeroderma pigmentosum; Xeroderma Pigmentosum - complications; Xeroderma Pigmentosum - genetics; Xeroderma Pigmentosum Group A Protein - genetics
• ISSN: 0378-6323; 0973-3922; 1998-3611
• DOI: 10.4103/0378-6323.148559

Xeroderma pigmentosum (XP) is an autosomal recessive genetic disorder characterized by cutaneous and ocular photosensitivity and an increased risk of developing cutaneous neoplasms. Progressive neurological abnormalities develop in a quarter of XP patients. To study the clinical profile and perform a mutation analysis in Indian patients with xeroderma pigmentosum. Ten families with 13 patients with XP were referred to our clinic over 2 years. The genes XPA, XPB and XPC were sequentially analyzed till a pathogenic mutation was identified. Homozygous mutations in the XPA gene were seen in patients with moderate to severe mental retardation (6/10 families) but not in those without neurological features. Two unrelated families with a common family name and belonging to the same community from Maharashtra were found to have an identical mutation in the XPA gene, namely c.335_338delTTATinsCATAAGAAA (p.F112SfsX2). Testing of the XPC gene in two families with four affected children led to the identification of the novel mutations c.1243C>T or p.R415X and c.1677C>A or p.Y559X. In two families, mutations could not be identified in XPA, XPB and XPC genes. The sample size is small. Indian patients who have neurological abnormalities associated with XP should be screened for mutations in the XPA gene.